We found that higher breast cancer risk associated with enhancers and strong/weak transcriptions were mainly in loci with low TF scores, while lower breast cancer risk associated with heterochromatin were mainly in loci with high TF scores, with significant interactions (P = 6 × 10−5; Fig. 4d; Supplementary Data 3). This evidence concerns the gene TF and breast carcinoma.